Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study

Doaa Nada,1 Rasha Gaber,2 Al Shymaa Mahmoud,3 Radwa Elkhouly,1 Doaa Alashkar1 1Rheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, Egypt; 2Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nada D, Gaber R, Mahmoud AS, Elkhouly R, Alashkar D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/896c9a6bae89442ca38134bb0a1337ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:896c9a6bae89442ca38134bb0a1337ef
record_format dspace
spelling oai:doaj.org-article:896c9a6bae89442ca38134bb0a1337ef2021-12-02T17:41:28ZHyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study1179-156Xhttps://doaj.org/article/896c9a6bae89442ca38134bb0a1337ef2021-10-01T00:00:00Zhttps://www.dovepress.com/hyperuricemia-among-egyptian-rheumatoid-arthritis-patients-is-it-an-as-peer-reviewed-fulltext-article-OARRRhttps://doaj.org/toc/1179-156XDoaa Nada,1 Rasha Gaber,2 Al Shymaa Mahmoud,3 Radwa Elkhouly,1 Doaa Alashkar1 1Rheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, Egypt; 2Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, Egypt; 3Radiology Departments, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, EgyptCorrespondence: Doaa NadaRheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Geish Street, Tanta, Al Gharbeia Governorate, EgyptTel +201069579672Fax +23286114040Email doaa.waseem@yahoo.comObjective: To detect the prevalence of hyperuricemia in Egyptian rheumatoid arthritis (RA) patients as well as to assess its association with the severity of joint inflammation and disease-modifying antirheumatic drugs (DMARDs) in those patients.Methods: A total of 150 RA patients were recruited; all patients were subjected to (1) clinical and functional assessment by disease activity score in 28 joints (DAS28) and modified health assessment questionnaire (MHAQ). (2) Laboratory investigations: serum uric acid (SUA) level, complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), tumor necrosis factor α (TNF-α), interleukin 1 (IL1), and interleukin 6 (IL6) levels. (3) Radiological evaluation: (A) plain X-ray of both hands and feet; (B) musculoskeletal ultrasound (MSUS) of both wrists, hands, shoulder, ankle, and knee joints.Results: SUA was significantly correlated with disease activity by DAS28. Acute-phase reactants and inflammatory markers (IL1β, IL6, and TNF-α) were also significantly elevated in RA patients with low and high hyperuricemia compared to those with normal SUA. A total of 90% of RA patients with low hyperuricemia had synovial proliferation with power Doppler (1+ and 2+), and 30 patients had mild effusion (1+), while nearly all patients with high hyperuricemia had hypoechoic synovial proliferation (2+ and 3+), and 20 patients had moderate effusion. However, 70% RA patients with normal serum uric acid showed mild synovitis and effusion (1+). No significant association was found between the administered DMARDs and levels of SUA as well as inflammatory markers; however, high-dose steroid treatment was associated with high SUA level.Conclusion: Elevation of serum uric acid levels in Egyptian RA patients was prevalent and might be an inflammatory marker for severity of joint inflammation. Moreover, higher doses of steroids could be considered a cause of hyperuricemia.Keywords: rheumatoid arthritis, uric acid, inflammatory marker, hyperuricemiaNada DGaber RMahmoud ASElkhouly RAlashkar DDove Medical Pressarticlerheumatoid arthritisuric acidinflammatory markerhyperuricemiaDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 13, Pp 305-314 (2021)
institution DOAJ
collection DOAJ
language EN
topic rheumatoid arthritis
uric acid
inflammatory marker
hyperuricemia
Diseases of the musculoskeletal system
RC925-935
spellingShingle rheumatoid arthritis
uric acid
inflammatory marker
hyperuricemia
Diseases of the musculoskeletal system
RC925-935
Nada D
Gaber R
Mahmoud AS
Elkhouly R
Alashkar D
Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
description Doaa Nada,1 Rasha Gaber,2 Al Shymaa Mahmoud,3 Radwa Elkhouly,1 Doaa Alashkar1 1Rheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, Egypt; 2Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, Egypt; 3Radiology Departments, Faculty of Medicine, Tanta University, Tanta, Al Gharbeia Governorate, EgyptCorrespondence: Doaa NadaRheumatology and Rehabilitation Department, Faculty of Medicine, Tanta University, Geish Street, Tanta, Al Gharbeia Governorate, EgyptTel +201069579672Fax +23286114040Email doaa.waseem@yahoo.comObjective: To detect the prevalence of hyperuricemia in Egyptian rheumatoid arthritis (RA) patients as well as to assess its association with the severity of joint inflammation and disease-modifying antirheumatic drugs (DMARDs) in those patients.Methods: A total of 150 RA patients were recruited; all patients were subjected to (1) clinical and functional assessment by disease activity score in 28 joints (DAS28) and modified health assessment questionnaire (MHAQ). (2) Laboratory investigations: serum uric acid (SUA) level, complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), tumor necrosis factor α (TNF-α), interleukin 1 (IL1), and interleukin 6 (IL6) levels. (3) Radiological evaluation: (A) plain X-ray of both hands and feet; (B) musculoskeletal ultrasound (MSUS) of both wrists, hands, shoulder, ankle, and knee joints.Results: SUA was significantly correlated with disease activity by DAS28. Acute-phase reactants and inflammatory markers (IL1β, IL6, and TNF-α) were also significantly elevated in RA patients with low and high hyperuricemia compared to those with normal SUA. A total of 90% of RA patients with low hyperuricemia had synovial proliferation with power Doppler (1+ and 2+), and 30 patients had mild effusion (1+), while nearly all patients with high hyperuricemia had hypoechoic synovial proliferation (2+ and 3+), and 20 patients had moderate effusion. However, 70% RA patients with normal serum uric acid showed mild synovitis and effusion (1+). No significant association was found between the administered DMARDs and levels of SUA as well as inflammatory markers; however, high-dose steroid treatment was associated with high SUA level.Conclusion: Elevation of serum uric acid levels in Egyptian RA patients was prevalent and might be an inflammatory marker for severity of joint inflammation. Moreover, higher doses of steroids could be considered a cause of hyperuricemia.Keywords: rheumatoid arthritis, uric acid, inflammatory marker, hyperuricemia
format article
author Nada D
Gaber R
Mahmoud AS
Elkhouly R
Alashkar D
author_facet Nada D
Gaber R
Mahmoud AS
Elkhouly R
Alashkar D
author_sort Nada D
title Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
title_short Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
title_full Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
title_fullStr Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
title_full_unstemmed Hyperuricemia Among Egyptian Rheumatoid Arthritis Patients. Is It an Association or an Inflammatory Marker? A Cross-Sectional Observational Study
title_sort hyperuricemia among egyptian rheumatoid arthritis patients. is it an association or an inflammatory marker? a cross-sectional observational study
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/896c9a6bae89442ca38134bb0a1337ef
work_keys_str_mv AT nadad hyperuricemiaamongegyptianrheumatoidarthritispatientsisitanassociationoraninflammatorymarkeracrosssectionalobservationalstudy
AT gaberr hyperuricemiaamongegyptianrheumatoidarthritispatientsisitanassociationoraninflammatorymarkeracrosssectionalobservationalstudy
AT mahmoudas hyperuricemiaamongegyptianrheumatoidarthritispatientsisitanassociationoraninflammatorymarkeracrosssectionalobservationalstudy
AT elkhoulyr hyperuricemiaamongegyptianrheumatoidarthritispatientsisitanassociationoraninflammatorymarkeracrosssectionalobservationalstudy
AT alashkard hyperuricemiaamongegyptianrheumatoidarthritispatientsisitanassociationoraninflammatorymarkeracrosssectionalobservationalstudy
_version_ 1718379655542603776